Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma - PubMed (original) (raw)

. 2017 May;39(5):1010428317701646.

doi: 10.1177/1010428317701646.

Affiliations

• PMID: 28466785
• DOI: 10.1177/1010428317701646

Free article

Identification of plasma microRNAs as new potential biomarkers with high diagnostic power in human cutaneous melanoma

Stefano Fogli et al. Tumour Biol. 2017 May.

Free article

Abstract

Melanoma is a devastating disease with few therapeutic options in the advanced stage and with the urgent need of reliable biomarkers for early detection. In this context, circulating microRNAs are raising great interest as diagnostic biomarkers. We analyzed the expression profiles of 21 selected microRNAs in plasma samples from melanoma patients and healthy donors to identify potential diagnostic biomarkers. Data analysis was performed using global mean normalization and NormFinder algorithm. Linear regression followed by receiver operating characteristic analyses was carried out to evaluate whether selected plasma miRNAs were able to discriminate between cases and controls. We found five microRNAs that were differently expressed among cases and controls after Bonferroni correction for multiple testing. Specifically, miR-15b-5p, miR-149-3p, and miR-150-5p were up-regulated in plasma of melanoma patients compared with healthy controls, while miR-193a-3p and miR-524-5p were down-regulated. Receiver operating characteristic analyses of these selected microRNAs provided area under the receiver operating characteristic curve values ranging from 0.80 to 0.95. Diagnostic value of microRNAs is improved when considering the combination of miR-149-3p, miR-150-5p, and miR-193a-3p. The triple classifier had a high capacity to discriminate between melanoma patients and healthy controls, making it suitable to be used in early melanoma diagnosis.

Keywords: MicroRNA; melanoma; plasma biomarkers.

PubMed Disclaimer

Similar articles

• The Potential of Circulating miR-193b, miR-146b-3p and miR-483-3p as Noninvasive Biomarkers in Cutaneous Melanoma Patients.
  Mohammadloo A, Asgari Y, Esmaeili-Bandboni A, Mazloomi MA, Ghasemi SF, Ameri S, Miri SR, Hamzelou S, Mahmoudi HR, Veisi-Malekshahi Z. Mohammadloo A, et al. Mol Biotechnol. 2024 Oct;66(10):2830-2840. doi: 10.1007/s12033-023-00893-x. Epub 2023 Nov 7. Mol Biotechnol. 2024. PMID: 37934389
• Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
  Wang L, Liu Y, Du L, Li J, Jiang X, Zheng G, Qu A, Wang H, Wang L, Zhang X, Liu H, Pan H, Yang Y, Wang C. Wang L, et al. Mol Med Rep. 2015 Jul;12(1):615-22. doi: 10.3892/mmr.2015.3428. Epub 2015 Mar 4. Mol Med Rep. 2015. PMID: 25738263
• Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer.
  Zhang J, Song Y, Zhang C, Zhi X, Fu H, Ma Y, Chen Y, Pan F, Wang K, Ni J, Jin W, He X, Su H, Cui D. Zhang J, et al. Theranostics. 2015 Apr 5;5(7):733-45. doi: 10.7150/thno.10305. eCollection 2015. Theranostics. 2015. PMID: 25897338 Free PMC article.
• Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma.
  Carpi S, Polini B, Fogli S, Podestà A, Ylösmäki E, Cerullo V, Romanini A, Nieri P. Carpi S, et al. Expert Rev Mol Diagn. 2020 Jan;20(1):19-30. doi: 10.1080/14737159.2020.1696194. Epub 2019 Nov 27. Expert Rev Mol Diagn. 2020. PMID: 31747311 Review.
• Circulating MicroRNA Biomarkers in Melanoma: Tools and Challenges in Personalised Medicine.
  Mumford SL, Towler BP, Pashler AL, Gilleard O, Martin Y, Newbury SF. Mumford SL, et al. Biomolecules. 2018 Apr 26;8(2):21. doi: 10.3390/biom8020021. Biomolecules. 2018. PMID: 29701682 Free PMC article. Review.

Cited by

• Tumor Suppressor Role of hsa-miR-193a-3p and -5p in Cutaneous Melanoma.
  Polini B, Carpi S, Doccini S, Citi V, Martelli A, Feola S, Santorelli FM, Cerullo V, Romanini A, Nieri P. Polini B, et al. Int J Mol Sci. 2020 Aug 27;21(17):6183. doi: 10.3390/ijms21176183. Int J Mol Sci. 2020. PMID: 32867069 Free PMC article.
• miR-149 in Human Cancer: A Systemic Review.
  He Y, Yu D, Zhu L, Zhong S, Zhao J, Tang J. He Y, et al. J Cancer. 2018 Jan 1;9(2):375-388. doi: 10.7150/jca.21044. eCollection 2018. J Cancer. 2018. PMID: 29344284 Free PMC article. Review.
• Circulating microRNAs as diagnostic biomarkers for melanoma: a systematic review and meta-analysis.
  Wu N, Sun H, Sun Q, Zhang F, Ma L, Hu Y, Cong X. Wu N, et al. BMC Cancer. 2023 May 8;23(1):414. doi: 10.1186/s12885-023-10891-6. BMC Cancer. 2023. PMID: 37158840 Free PMC article.
• Cell-autonomous and cell non-autonomous downregulation of tumor suppressor DAB2IP by microRNA-149-3p promotes aggressiveness of cancer cells.
  Bellazzo A, Di Minin G, Valentino E, Sicari D, Torre D, Marchionni L, Serpi F, Stadler MB, Taverna D, Zuccolotto G, Montagner IM, Rosato A, Tonon F, Zennaro C, Agostinis C, Bulla R, Mano M, Del Sal G, Collavin L. Bellazzo A, et al. Cell Death Differ. 2018 Jul;25(7):1224-1238. doi: 10.1038/s41418-018-0088-5. Epub 2018 Mar 22. Cell Death Differ. 2018. PMID: 29568059 Free PMC article.
• Integrated Assessment of Circulating Cell-Free MicroRNA Signatures in Plasma of Patients with Melanoma Brain Metastasis.
  Bustos MA, Tran KD, Rahimzadeh N, Gross R, Lin SY, Shoji Y, Murakami T, Boley CL, Tran LT, Cole H, Kelly DF, O'Day S, Hoon DSB. Bustos MA, et al. Cancers (Basel). 2020 Jun 25;12(6):1692. doi: 10.3390/cancers12061692. Cancers (Basel). 2020. PMID: 32630542 Free PMC article.

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Other Literature Sources

  • The Lens - Patent Citations Database
  • scite Smart Citations

• Medical

  • MedlinePlus Health Information